Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus

Rheumatology (Oxford). 2005 Nov;44(11):1462-4. doi: 10.1093/rheumatology/kei075. Epub 2005 Aug 16.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Anti-Idiotypic / blood*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Drug Resistance
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Recombinant Fusion Proteins / immunology
  • Rituximab

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Recombinant Fusion Proteins
  • Rituximab